AHA 2024 - Marc Bonaca presents the results of a sub-study from the CLEAR Outcomes trial on the effects of bempedoic acid on adverse limb event in statin-intolerant patients with symptomatic peripheral artery disease (PAD).
Bempedoic acid reduces adverse limb events in patients with PAD
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Marc Bonaca, MD is a cardiologist and vascular medicine specialist and is the executive director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 21 November 2024
Recommended
Details
Presenters
Overview
AHA 2024 - Marc Bonaca presents the results of a sub-study from the CLEAR Outcomes trial on the effects of bempedoic acid on adverse limb event in statin-intolerant patients with symptomatic peripheral artery disease (PAD).
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Marc Bonaca, MD is a cardiologist and vascular medicine specialist and is the executive director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 21 November 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
Advances in Women's Health
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
<p>Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients</p>
Advances in Women's Health
Reducing the Risk of Postpartum Depression Through Sleep Interventions
<p>Reducing the Risk of Postpartum Depression Through Sleep Interventions<strong> </strong></p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
Clinician's Roundtable
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
<p>Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?